Connection

Roberto Caporali to Hydroxychloroquine

Back to Details
This is a "connection" page, showing publications Roberto Caporali has written about Hydroxychloroquine.
Roberto Caporali
Connection Strength
0.161
Hydroxychloroquine
  1. COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients. Semin Arthritis Rheum. 2020 10; 50(5):1150-1157.
    View in: PubMed
    Score: 0.039
  2. Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients. Ann Rheum Dis. 2021 05; 80(5):e75.
    View in: PubMed
    Score: 0.039
  3. Are patients with systemic lupus erythematosus at increased risk for COVID-19? Ann Rheum Dis. 2021 02; 80(2):e25.
    View in: PubMed
    Score: 0.039
  4. Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial. Clin Rheumatol. 2019 Mar; 38(3):841-849.
    View in: PubMed
    Score: 0.035
  5. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country. Pediatr Rheumatol Online J. 2020 Apr 22; 18(1):35.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.